Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2007-09-04
2007-09-04
Zeman, Robert A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S855000
Reexamination Certificate
active
10527771
ABSTRACT:
The present invention relates to nucleic acid sequences encodingOstertagia ostertagiproteins and to parts of such nucleic acid sequences that encode an immunogenic fragment of such proteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relate toOstertagia ostertagiproteins and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, proteins or immunogenic parts thereof and antibodies against such proteins or immunogenic thereof. Also, the inventions relates to the use of said proteins in vaccines and for the manufacture of vaccines. Moreover, the invention relates to the use of aid nucleic acid sequences, proteins or antibodies for diagnostic or vaccination purposes. Finally the invention relates to diagnostic kits comprising such nucleic acids, proteins or antibodies against such proteins.
REFERENCES:
patent: 3395218 (1968-07-01), Hyman
patent: 6017757 (2000-01-01), Coyne
patent: 6232086 (2001-05-01), Pastan et al.
patent: 6248329 (2001-06-01), Chandrashekar et al.
patent: WO95 09182 (1995-04-01), None
Bowie et al, Science, 1990, 247:1306-1310.
Burgess et al, J. of Cell Bio. 111:2129-2138, 1990.
Lazar et al., Molecular and Cellular Biology, 1988, 8:1247-1252.
Bork, Genome Research, 2000, 10:398-400.
Ellis (Chapter 29 of Vaccines, Plistkin, et al. (eds) WB Saunders, Philadelphia, 1998,pp. 568-575.
Vercauteren, Isabel et al. “Identification of excretory-secretory products of larval . . . ” Molecular and Biochem. Parasitology (Feb. 2003) V126, N2, p. 201-208, XP-001156729.
Chen, Jeng-Shong et al. “Extensive Sequence Conservation Among Insect, Nematode,and . . . ” J. of Molecular Evolution (1997) V44, p. 440-451, XP-002264414.
De Maere, V., et al., “Identification of potential protective antigens of Ostertagia ostertagi . . . ” Parasitology, Oct. 2002, V 125. p 383-391.
EMBL Database, Mar. 31, 2001, EMBL Database accession No. AJ310819.
EMBL Database, May 14, 2001, EMBL Database accession No. BG733986.
Gencore accession No. AJ310812, Mar. 29, 2001 and Aug. 12, 2001.
Abstract submitted and slides presented during an oral presentation “Identification of protective antigens ofOstertagiaosterlagi” Moredun Research Inst. (Jul. 2-5, 2002).
Vercauteren, et al. “Isolation and Identification of In Vitro Released Excretory-Secretory Products of . . . ” May 04, 2001, Proceedings of meeting of Belgian Society for Parasitology.
Claerebout Edwin
De Maere Veerle
Geldhof Peter
Vercauteren Isabel
Vercruijsse Jozef
Blackstone William M.
Gangle Brian
Milsteed Mark W.
Schwartz Aaron L.
Universiteit Gent
LandOfFree
Ostertagia vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ostertagia vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ostertagia vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3756971